Update on Antithrombotic Agents in Secondar y Stroke Prevention

Tatjana Rundek, Vanja Bašić-Kes, Sandra Morović, Vida Demarin

Research output: Contribution to journalArticle

Abstract

Recurrent stroke is a major cause of morbidity and mortality among stroke survivors. With improved survival after first ischemic stroke, stroke recurrence may account for a greater share of the future annual cost of stroke-related health care. Despite advances in stroke prevention strategies and treatments, stroke recurrence is still the major threat to any stroke survivor. This review discusses antithrombotic therapy in secondary stroke prevention which has a major impact in clinical practice.

Original languageEnglish
Pages (from-to)101-106
Number of pages6
JournalActa Clinica Croatica
Volume50
Issue number1
StatePublished - Dec 1 2011

Fingerprint

Fibrinolytic Agents
Stroke
Survivors
Recurrence
Secondary Prevention
Morbidity
Delivery of Health Care
Costs and Cost Analysis
Survival
Mortality

Keywords

  • Anticoagulants
  • Platelet aggregation inhibitors
  • Prevention and control
  • Secondary prevention
  • Stroke
  • Therapeutic use

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rundek, T., Bašić-Kes, V., Morović, S., & Demarin, V. (2011). Update on Antithrombotic Agents in Secondar y Stroke Prevention. Acta Clinica Croatica, 50(1), 101-106.

Update on Antithrombotic Agents in Secondar y Stroke Prevention. / Rundek, Tatjana; Bašić-Kes, Vanja; Morović, Sandra; Demarin, Vida.

In: Acta Clinica Croatica, Vol. 50, No. 1, 01.12.2011, p. 101-106.

Research output: Contribution to journalArticle

Rundek, T, Bašić-Kes, V, Morović, S & Demarin, V 2011, 'Update on Antithrombotic Agents in Secondar y Stroke Prevention', Acta Clinica Croatica, vol. 50, no. 1, pp. 101-106.
Rundek T, Bašić-Kes V, Morović S, Demarin V. Update on Antithrombotic Agents in Secondar y Stroke Prevention. Acta Clinica Croatica. 2011 Dec 1;50(1):101-106.
Rundek, Tatjana ; Bašić-Kes, Vanja ; Morović, Sandra ; Demarin, Vida. / Update on Antithrombotic Agents in Secondar y Stroke Prevention. In: Acta Clinica Croatica. 2011 ; Vol. 50, No. 1. pp. 101-106.
@article{2323b434c0c74165bc3296163dc1702d,
title = "Update on Antithrombotic Agents in Secondar y Stroke Prevention",
abstract = "Recurrent stroke is a major cause of morbidity and mortality among stroke survivors. With improved survival after first ischemic stroke, stroke recurrence may account for a greater share of the future annual cost of stroke-related health care. Despite advances in stroke prevention strategies and treatments, stroke recurrence is still the major threat to any stroke survivor. This review discusses antithrombotic therapy in secondary stroke prevention which has a major impact in clinical practice.",
keywords = "Anticoagulants, Platelet aggregation inhibitors, Prevention and control, Secondary prevention, Stroke, Therapeutic use",
author = "Tatjana Rundek and Vanja Bašić-Kes and Sandra Morović and Vida Demarin",
year = "2011",
month = "12",
day = "1",
language = "English",
volume = "50",
pages = "101--106",
journal = "Acta Clinica Croatica",
issn = "0353-9466",
publisher = "Klinicka Bolnica Sestre Milosrdnice",
number = "1",

}

TY - JOUR

T1 - Update on Antithrombotic Agents in Secondar y Stroke Prevention

AU - Rundek, Tatjana

AU - Bašić-Kes, Vanja

AU - Morović, Sandra

AU - Demarin, Vida

PY - 2011/12/1

Y1 - 2011/12/1

N2 - Recurrent stroke is a major cause of morbidity and mortality among stroke survivors. With improved survival after first ischemic stroke, stroke recurrence may account for a greater share of the future annual cost of stroke-related health care. Despite advances in stroke prevention strategies and treatments, stroke recurrence is still the major threat to any stroke survivor. This review discusses antithrombotic therapy in secondary stroke prevention which has a major impact in clinical practice.

AB - Recurrent stroke is a major cause of morbidity and mortality among stroke survivors. With improved survival after first ischemic stroke, stroke recurrence may account for a greater share of the future annual cost of stroke-related health care. Despite advances in stroke prevention strategies and treatments, stroke recurrence is still the major threat to any stroke survivor. This review discusses antithrombotic therapy in secondary stroke prevention which has a major impact in clinical practice.

KW - Anticoagulants

KW - Platelet aggregation inhibitors

KW - Prevention and control

KW - Secondary prevention

KW - Stroke

KW - Therapeutic use

UR - http://www.scopus.com/inward/record.url?scp=84855161173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855161173&partnerID=8YFLogxK

M3 - Article

C2 - 22034789

AN - SCOPUS:84855161173

VL - 50

SP - 101

EP - 106

JO - Acta Clinica Croatica

JF - Acta Clinica Croatica

SN - 0353-9466

IS - 1

ER -